Skip to main content
CNSY
NASDAQ Industrial Applications And Services

Cerenome's $21.3M Convertible Note Deal with 3i, LP Carries Heavy Dilution Risk

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Negative
Importance info
8
Price
$2.61
Mkt Cap
$18.898M
52W Low
$2.489
52W High
$23.425
52W Position info
4.9% above low
Off High info
89% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

CNSY is trading near its 52-week low of $2.489 (4.9% above the low).

Summary

Cerenome disclosed full terms of its $21.3M convertible note financing with 3i, LP — including a $2.74 initial conversion price, $0.50 floor, 8% interest, and a 2.5% royalty on CNSide revenues. The deal provides runway into 2028 but carries heavy dilution and asset encumbrance risk.


Key Events · Financing and Capital Events · CNSY

  • Convertible Note Financing Terms

    Cerenome entered into a securities purchase agreement with 3i, LP for up to $21,276,596 in senior secured convertible notes — $3,191,489 Initial Notes, $2,127,660 Second Notes, and $15,957,447 Additional Notes.

  • Conversion Price and Dilution Risk

    Initial Notes convert at $2.74 per share with a $0.50 floor price. At the floor, the full $21.3M principal could convert into over 42 million shares — more than 5x the current 7.59 million outstanding.

  • Royalty Obligation on CNSide

    CNSide must pay 3i, LP a quarterly royalty of 2.5% of gross revenues, capped at 2.5% of the unpaid note balance, until all notes are repaid or cancelled.

  • First-Priority Security Interest

    The notes are secured by a first-priority lien on substantially all present and future assets of Cerenome and CNSide Diagnostics, including intellectual property and equity interests.


Analysis · CNSY · Industrial Applications And Services

A senior secured convertible note financing with 3i, LP provides Cerenome with up to $21.3 million in aggregate principal. The Initial Notes convert at $2.74 per share, a modest premium to the current $2.61 share price, but the structure includes a $0.50 floor price, 6% original issue discount, 8% interest, and a 2.5% royalty on CNSide revenues. The notes are secured by a first-priority lien on substantially all assets of Cerenome and its CNSide subsidiary. With only $8.6 million in cash as of Q2 2026 and a going concern warning already disclosed, this financing provides critical runway but at the cost of significant potential dilution and a royalty burden on the company's core diagnostic business. The exchange cap limits immediate conversion to 19.99% of outstanding shares without stockholder approval, but the full note structure could ultimately convert into a substantial portion of the company's equity.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CNSY was trading at $2.61 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $18.9M. The 52-week trading range was $2.49 to $23.43. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CNSY - Latest Insights

CNSY
Nov 16, 2026, 7:45 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9629
Real-time Price: $0.7418 info
Change: -$0.2211 (-23%) info
Market Cap: $6.867M info
CNSY
Nov 13, 2026, 5:19 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.9601
Real-time Price: $0.7418 info
Change: -$0.2183 (-23%) info
Market Cap: $6.867M info
CNSY
Nov 13, 2026, 5:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.7418 info
Change: -$0.2282 (-24%) info
Market Cap: $6.867M info
CNSY
Nov 13, 2026, 4:51 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9372
Real-time Price: $0.7418 info
Change: -$0.1954 (-21%) info
Market Cap: $6.867M info
CNSY
Nov 04, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.7418 info
Change: -$0.5682 (-43%) info
Market Cap: $6.867M info